|
本公眾號每天分享一篇最新一期Anesthesia & Analgesia等SCI雜志的摘要翻譯,敬請關(guān)注并提出寶貴意見 Premedication with oral paracetamol for reduction of propofol injection pain: a randomized placebo-controlled trial 背景與目的 比較預(yù)先口服兩種不同劑量乙酰氨基酚預(yù)防丙泊酚靜脈注射痛的效果。 方 法 本試驗為一項雙盲隨機對照試驗。在該試驗中,誘導(dǎo)前1小時予計劃靜脈注射丙泊酚行全麻誘導(dǎo)的患者分別口服安慰劑、500 mg或1000 mg對乙酰氨基酚(分別為p500和p1000)。丙泊酚給藥劑量為2mg/kg,注射速率為600 ml/h。當注射劑量占全部劑量的1/4后,暫停注射泵,要求患者使用從0到10的言語數(shù)字評分(VNRs)來評估注射部位的疼痛程度。 結(jié) 果 本研究共納入324例患者。P 500組和P 1000組(中間VNRs[四分位數(shù)范圍]分別=2[0-3]和4[2-5])患者疼痛強度均低于安慰劑組 (8 [7–10]; P < 0.001)。p1000組的疼痛發(fā)生率(70.4%)低于p500和安慰劑組(分別為86.1和99.1%;p<0.001)。P 1000組輕度(VNRs 1-3)、中度(VNRs 4-6)和重度疼痛(VNRs 7-10)的發(fā)生率分別為47.2%、23.2%和0%,P 500組分別為28.7%、50%和7.4%,安慰劑組分別為0、22.2%和76.9%(P<0.001)。3組耐受性相似。 結(jié) 論 口服對乙酰氨基酚可以減少丙泊酚靜脈注射時的疼痛。在當前的實踐中,為了避免患者對丙泊酚注射痛感到擔憂,這種耐受性好的、可獲得的和廉價的治療方法似乎是一種理想的選擇。 原始文獻摘要 Nimmaanrat S, Jongjidpranitarn M, Prathep S, et al. Premedication with oral paracetamol for reduction of propofol injection pain: a randomized placebo-controlled trial.[J] .BMC Anesthesiol, 2019, 19: 100. Background: To compare the effect of premedication with 2 different doses of oral paracetamol to prevent pain at propofol intravenous injection. Methods: We conducted a double-blind randomized controlled trial in which patients scheduled for induction of general anesthesia with intravenous propofol received either a placebo, 500 mg or 1000 mg of oral paracetamol (P500 and P1000, respectively) 1 h prior to induction. Two mg/kg of propofol was injected at a rate of 600 ml/hr. After 1/4 of the full dose had been injected, the syringe pump was paused, and patients were asked to rate pain at the injection site using a verbal numerical rating score (VNRS) from 0 to 10. Results: Three hundred and twenty-four patients were included. Pain intensity was lower in both P500 and P1000 groups (median VNRS [interquartile range] = 2 [0–3] and 4 [2–5], respectively) than in the placebo group (8 [7–10]; P < 0.001)*. The rate of pain was lower in the P1000 group (70.4%) than in both the P500 and the placebo group (86.1 and 99.1%, respectively; P < 0.001)*. The respective rates of mild (VNRS 1–3), moderate (VNRS 4–6) and severe pain (VNRS 7–10) were 47.2, 23.2 and 0% in the P1000 group, 28.7, 50 and 7.4% in the P500 group, and 0, 22.2 and 76.9% in the placebo group (P < 0.001* for between group comparisons). Tolerance was similar in the 3 groups. Conclusions: A premedication with oral paracetamol can dose-dependently reduce pain at propofol intravenous injection. To avoid this common uncomfortable concern for the patients, this well-tolerated, available and cheap treatment appears as an option to be implemented in the current practice. 麻醉學(xué)文獻進展分享 貴州醫(yī)科大學(xué)高鴻教授課題組 翻譯:何幼芹 編輯:何幼芹 審校:王貴龍 |
|
|
來自: 罌粟花anesthGH > 《待分類》